Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Neuroimmunomodulation ; 22(5): 279-92, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26074181

RESUMO

OBJECTIVE: Although psychological and/or physiological stress has been well documented to influence immune responses, the precise mechanism for immunomodulation remains to be elucidated. The present work describes the role of the hypothalamic-pituitary-adrenal (HPA) axis in the mechanism of stress-mediated enhanced-resistance to lethality after lipopolysaccharide (LPS) injection. METHODS/RESULTS: Preconditioning with restraint stress (RS) resulted in enhanced activation of the HPA axis in response to LPS injection and suppressed LPS-induced release of proinflammatory cytokines and nitric oxide metabolites. Melanocortin 2 receptor-deficient mice (MC2R(-/-)) failed to increase plasma levels of glucocorticoids in response to LPS injection, and exhibited high sensitivity to LPS-induced lethality with enhanced release of proinflammatory cytokines as compared with MC2R(+/-) mice. Real-time PCR analysis revealed that RS induced upregulation of uncoupling protein-2 (UCP2) in macrophages in the lung and the liver of MC2R(+/-), but not of MC2R(-/-), mice. In addition, RS increased UCP2-dependent uncoupling activity of isolated mitochondria from the liver of MC2R(+/-), but not of MC2R(-/-), mice. In vitro study revealed that corticosterone and dexamethasone directly increased UCP2 expression in mouse RAW 264.7 macrophages and suppressed the generation of LPS-induced mitochondrial reactive oxygen species (ROS) and TNF-α production. Knockdown of UCP2 by small interfering RNA blunted the dexamethasone action for suppressing LPS-induced mitochondrial ROS and TNF-α production. CONCLUSION: The present work suggests that RS enhances activation of the HPA axis to release glucocorticoids and upregulation of UCP2 in macrophages, thereby increasing the resistance to endotoxin-induced systemic inflammation and death.


Assuntos
Glucocorticoides/metabolismo , Canais Iônicos/metabolismo , Proteínas Mitocondriais/metabolismo , Estresse Psicológico/metabolismo , Regulação para Cima/fisiologia , Hormônio Adrenocorticotrópico/metabolismo , Animais , Linhagem Celular Transformada , Corticosterona/metabolismo , Citocinas/metabolismo , Modelos Animais de Doenças , Lipopolissacarídeos/farmacologia , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Óxido Nítrico/metabolismo , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Receptor Tipo 2 de Melanocortina/deficiência , Receptor Tipo 2 de Melanocortina/genética , Proteína Desacopladora 2 , Regulação para Cima/efeitos dos fármacos
2.
J Mol Endocrinol ; 56(4): T135-56, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-26793988

RESUMO

The pituitary adrenocorticotropic hormone (ACTH) plays a pivotal role in homeostasis and stress response and is thus the major component of the hypothalamo-pituitary-adrenal axis. After a brief summary of ACTH production from proopiomelanocortin (POMC) and on ACTH receptor properties, the first part of the review covers the role of ACTH in steroidogenesis and steroid secretion. We highlight the mechanisms explaining the differential acute vs chronic effects of ACTH on aldosterone and glucocorticoid secretion. The second part summarizes the effects of ACTH on adrenal growth, addressing its role as either a mitogenic or a differentiating factor. We then review the mechanisms involved in steroid secretion, from the classical Cyclic adenosine monophosphate second messenger system to various signaling cascades. We also consider how the interaction between the extracellular matrix and the cytoskeleton may trigger activation of signaling platforms potentially stimulating or repressing the steroidogenic potency of ACTH. Finally, we consider the extra-adrenal actions of ACTH, in particular its role in differentiation in a variety of cell types, in addition to its known lipolytic effects on adipocytes. In each section, we endeavor to correlate basic mechanisms of ACTH function with the pathological consequences of ACTH signaling deficiency and of overproduction of ACTH.


Assuntos
Glândulas Suprarrenais/metabolismo , Hormônio Adrenocorticotrópico/metabolismo , Adipócitos/metabolismo , Córtex Suprarrenal/metabolismo , Córtex Suprarrenal/patologia , Corticosteroides/biossíntese , Glândulas Suprarrenais/efeitos dos fármacos , Glândulas Suprarrenais/crescimento & desenvolvimento , Aldosterona/metabolismo , Animais , Citoesqueleto/metabolismo , Suscetibilidade a Doenças , Matriz Extracelular/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Genômica/métodos , Humanos , Sistema de Sinalização das MAP Quinases , Periodicidade , Ligação Proteica , Espécies Reativas de Oxigênio/metabolismo , Receptor Tipo 2 de Melanocortina/deficiência , Receptor Tipo 2 de Melanocortina/genética , Receptor Tipo 2 de Melanocortina/metabolismo , Transdução de Sinais/efeitos dos fármacos , Esteroides/biossíntese
3.
Best Pract Res Clin Endocrinol Metab ; 23(2): 159-65, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19500760

RESUMO

Familial glucocorticoid deficiency is an autosomal recessive disorder resulting from defects in the action of adrenocorticotropic hormone (ACTH) to stimulate glucocorticoid synthesis in the adrenal. Production of mineralocorticoids by the adrenal is normal. Patients present in early life with low or undetectable cortisol and--because of the failure of the negative feedback loop to the pituitary and hypothalamus--grossly elevated ACTH levels. About half of all cases result from mutations in the ACTH receptor (melanocortin 2 receptor) or from mutations in the melanocortin 2 receptor accessory protein (MRAP), but other genetic causes of this potentially lethal disorder remain to be discovered.


Assuntos
Doenças do Sistema Endócrino/genética , Glucocorticoides/deficiência , Glucocorticoides/genética , Hormônio Adrenocorticotrópico/fisiologia , Animais , Modelos Animais de Doenças , Doenças do Sistema Endócrino/diagnóstico , Glucocorticoides/biossíntese , Humanos , Camundongos , Receptor Tipo 2 de Melanocortina/deficiência , Receptor Tipo 2 de Melanocortina/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA